首页> 外文期刊>Sleep & breathing =: Schlaf & Atmung >Variables affecting the change in systemic blood pressure in response to nasal CPAP in obstructive sleep apnea patients.
【24h】

Variables affecting the change in systemic blood pressure in response to nasal CPAP in obstructive sleep apnea patients.

机译:影响阻塞性睡眠呼吸暂停患者鼻CPAP引起的全身血压变化的变量。

获取原文
获取原文并翻译 | 示例
           

摘要

We hypothesized that an improvement in systemic blood pressure (BP) during continuous positive airway pressure (CPAP) treatment of obstructive sleep apnea (OSA) would be related to severity of hypertension (HTN), morphometric parameters such as body mass index, and level of CPAP adherence. We tested this hypothesis with a retrospective review of 85 consecutive OSA patients who had completed diagnostic and CPAP titration polysomnograms and were equipped with a CPAP-adherence monitoring system for a minimum of 1 month of observation. Sphygmomanometer-obtained BP readings were compared at baseline and after 4-6 weeks of CPAP therapy. Presentation BP was significantly and strongly associated with the change in BP seen with treatment. Those with an elevated systolic and diastolic BP and those with an elevation of either systolic or diastolic BP showed a significant fall in BP on CPAP. Those with a BP below the hypertensive range of 140/90 on presentation did not have a significant drop in BP with CPAP. There were no significant changes in systolic, diastolic, or mean BP when patients were categorized by the severity of HTN, as determined by the number of antihypertensive medications prescribed or if they were categorized by the degree of CPAP adherence, objectively determined by the average use of more or less than 4 hight. We conclude that HTN at initial presentation is among the most important indicators of potential benefit of CPAP administration on BP.
机译:我们假设持续性气道正压通气(CPAP)治疗阻塞性睡眠呼吸暂停(OSA)期间系统血压(BP)的改善将与高血压(HTN)的严重程度,形态参数(例如体重指数)和遵守CPAP。我们通过回顾性检查了85名连续完成诊断和CPAP滴定多导睡眠图并配备CPAP粘附监测系统至少1个月的OSA患者来检验该假设。在基线和CPAP治疗4-6周后比较血压计获得的BP读数。表现BP与治疗中观察到的BP变化显着且强烈相关。收缩压和舒张压升高的患者以及收缩压或舒张压升高的患者在CPAP上均显示BP明显下降。血压低于140/90的血压者,CPAP的血压没有明显下降。按照HTN的严重程度对患者进行分类时,其收缩压,舒张压或平均BP值均无显着变化,这取决于所开的降压药物的数量或根据CPAP依从程度进行分类(由平均使用量客观地确定)多于或少于4小时/晚。我们得出的结论是,初次出现HTN是CPAP管理对BP潜在益处的最重要指标之一。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号